132 related articles for article (PubMed ID: 6699074)
1. The pattern of the mononuclear infiltrate as a prognostic parameter in flat superficial spreading melanomas.
Bröcker EB; Kolde G; Steinhausen D; Peters A; Macher E
J Cancer Res Clin Oncol; 1984; 107(1):48-52. PubMed ID: 6699074
[TBL] [Abstract][Full Text] [Related]
2. Clinical features of superficial spreading melanomas with zones of regression.
Czarnetzki BM; Denter M; Bröcker EB; Rümke P; Krieg V; Vakilzadeh F; Macher E
J Cancer Res Clin Oncol; 1984; 107(3):225-8. PubMed ID: 6736111
[TBL] [Abstract][Full Text] [Related]
3. Relevance of vertical growth pattern in thin level II cutaneous superficial spreading melanomas.
Lefevre M; Vergier B; Balme B; Thiebault R; Delaunay M; Thomas L; Beylot-Barry M; Machet L; De Muret A; Bioulac-Sage P; Bailly C
Am J Surg Pathol; 2003 Jun; 27(6):717-24. PubMed ID: 12766575
[TBL] [Abstract][Full Text] [Related]
4. Decreased tumor-infiltrating lymphocytes in nodular melanomas compared with matched superficial spreading melanomas.
Lin RL; Wang TJ; Joyce CJ; Mihm MC; Murphy GF; Lian CG; Lin JY
Melanoma Res; 2016 Oct; 26(5):524-7. PubMed ID: 26974966
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic features and behavior of cutaneous eyelid melanoma.
Vaziri M; Buffam FV; Martinka M; Oryschak A; Dhaliwal H; White VA
Ophthalmology; 2002 May; 109(5):901-8. PubMed ID: 11986095
[TBL] [Abstract][Full Text] [Related]
6. Head and neck melanoma in 534 clinical Stage I patients. A prognostic factors analysis and results of surgical treatment.
Urist MM; Balch CM; Soong SJ; Milton GW; Shaw HM; McGovern VJ; Murad TM; McCarthy WH; Maddox WA
Ann Surg; 1984 Dec; 200(6):769-75. PubMed ID: 6508408
[TBL] [Abstract][Full Text] [Related]
7. Disease progression in patients with thin cutaneous melanomas (tumour thickness < or = 0.75 mm): clinical and epidemiological data from the Tumour Center Munich 1977-98.
Schmid-Wendtner MH; Baumert J; Eberle J; Plewig G; Volkenandt M; Sander CA
Br J Dermatol; 2003 Oct; 149(4):788-93. PubMed ID: 14616371
[TBL] [Abstract][Full Text] [Related]
8. [Malignant melanoma: depth of invasion and histologic typing].
Hermanek P; Hornstein OP; Tonak J; Weidner F
Beitr Pathol; 1976 May; 157(3):269-82. PubMed ID: 1275868
[TBL] [Abstract][Full Text] [Related]
9. "Small" melanomas: relation of prognostic variables to diameter of primary superficial spreading melanomas.
Kopf AW; Rodríguez-Sains RS; Rigel DS; Friedman RJ; Bart RS; Grier WR; Mintzis MM; Postel AH
J Dermatol Surg Oncol; 1982 Sep; 8(9):765-70. PubMed ID: 7130508
[TBL] [Abstract][Full Text] [Related]
10. Image analysis of stage 1 melanoma (1.00-2.50 mm): lymphocytic infiltrates related to metastasis and survival.
Pastorfide GC; Kibbi AG; de Roa AL; Barnhill RL; Sober AJ; Mihm MC; Byers HR
J Cutan Pathol; 1992 Oct; 19(5):390-7. PubMed ID: 1474192
[TBL] [Abstract][Full Text] [Related]
11. Melanocytic nevi in histologic association with primary cutaneous melanoma of superficial spreading and nodular types: effect of tumor thickness.
Sagebiel RW
J Invest Dermatol; 1993 Mar; 100(3):322S-325S. PubMed ID: 8440914
[TBL] [Abstract][Full Text] [Related]
12. Thin (less than or equal to 1 mm) melanomas of the extremities are biologically favorable lesions not influenced by regression.
Wanebo HJ; Cooper PH; Hagar RW
Ann Surg; 1985 Apr; 201(4):499-504. PubMed ID: 3977452
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of DNA ploidy and degree of DNA abnormality in benign and malignant melanocytic lesions of the skin using video imaging.
Pilch H; Günzel S; Schäffer U; Tanner B; Heine M
Cancer; 2000 Mar; 88(6):1370-7. PubMed ID: 10717619
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors in thin cutaneous malignant melanoma.
Månsson-Brahme E; Carstensen J; Erhardt K; Lagerlöf B; Ringborg U; Rutqvist LE
Cancer; 1994 May; 73(9):2324-32. PubMed ID: 8168037
[TBL] [Abstract][Full Text] [Related]
15. A single-institution assessment of superficial spreading melanoma (SSM) in the pediatric population: Molecular and histopathologic features compared with adult SSM.
Verzì AE; Bubley JA; Haugh AM; Zhang B; Wagner A; Kruse L; West DP; Wayne J; Guitart J; Gerami P
J Am Acad Dermatol; 2017 Nov; 77(5):886-892. PubMed ID: 28754310
[TBL] [Abstract][Full Text] [Related]
16. Thin cutaneous malignant melanomas (< or =1.5 mm): identification of risk factors indicative of progression.
Massi D; Franchi A; Borgognoni L; Reali UM; Santucci M
Cancer; 1999 Mar; 85(5):1067-76. PubMed ID: 10091790
[TBL] [Abstract][Full Text] [Related]
17. [Histologic criteria for the diagnosis of superficially spreading melanoma in patients with proven metastases].
Jakić-Razumović J; Cacić-Pilipović M; Cuzić S
Acta Med Croatica; 1991; 45(4-5):325-33. PubMed ID: 1726516
[TBL] [Abstract][Full Text] [Related]
18. Regression in thin malignant melanoma. Microscopic diagnosis and prognostic importance.
Cooper PH; Wanebo HJ; Hagar RW
Arch Dermatol; 1985 Sep; 121(9):1127-31. PubMed ID: 4037837
[TBL] [Abstract][Full Text] [Related]
19. Autologous melanoma vaccine induces inflammatory responses in melanoma metastases: relevance to immunologic regression and immunotherapy.
Murphy GF; Radu A; Kaminer M; Berd D
J Invest Dermatol; 1993 Mar; 100(3):335S-341S. PubMed ID: 8440919
[TBL] [Abstract][Full Text] [Related]
20. Differences in chromosomal aberrations between nodular and superficial spreading malignant melanoma detected by interphase cytogenetics.
Poetsch M; Woenckhaus C; Dittberner T; Pambor M; Lorenz G; Herrmann FH
Lab Invest; 1998 Jul; 78(7):883-8. PubMed ID: 9690566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
